Cost-effectiveness considerations for managed care systems: Treating depression in primary care

Bentson McFarland

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

This article addresses the management of depression in primary care from the perspective of a health maintenance organization. The rise of managed care systems is briefly discussed with reference to their impact on choice of treatment strategies. Cost-effectiveness considerations pertinent to a health maintenance organization are reviewed. A simplified protocol for the treatment of depression with paroxetine or imipramine in the primary care sector is presented and used as an example of cost calculations. Given the assumptions used in this cost-effectiveness model, it appears that the costs of treating depression in primary care with paroxetine are approximately equal to those found with the use of imipramine. Higher acquisition costs of paroxetine are balanced by the greater labor costs associated with imipramine.

Original languageEnglish (US)
JournalThe American journal of medicine
Volume97
Issue number6 SUPPL. 1
DOIs
StatePublished - Dec 19 1994

Fingerprint

Managed Care Programs
Paroxetine
Cost-Benefit Analysis
Imipramine
Primary Health Care
Costs and Cost Analysis
Health Maintenance Organizations
Clinical Protocols
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Cost-effectiveness considerations for managed care systems : Treating depression in primary care. / McFarland, Bentson.

In: The American journal of medicine, Vol. 97, No. 6 SUPPL. 1, 19.12.1994.

Research output: Contribution to journalArticle

@article{6df5b63556c54646977be2edd84ad503,
title = "Cost-effectiveness considerations for managed care systems: Treating depression in primary care",
abstract = "This article addresses the management of depression in primary care from the perspective of a health maintenance organization. The rise of managed care systems is briefly discussed with reference to their impact on choice of treatment strategies. Cost-effectiveness considerations pertinent to a health maintenance organization are reviewed. A simplified protocol for the treatment of depression with paroxetine or imipramine in the primary care sector is presented and used as an example of cost calculations. Given the assumptions used in this cost-effectiveness model, it appears that the costs of treating depression in primary care with paroxetine are approximately equal to those found with the use of imipramine. Higher acquisition costs of paroxetine are balanced by the greater labor costs associated with imipramine.",
author = "Bentson McFarland",
year = "1994",
month = "12",
day = "19",
doi = "10.1016/0002-9343(94)90363-8",
language = "English (US)",
volume = "97",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "6 SUPPL. 1",

}

TY - JOUR

T1 - Cost-effectiveness considerations for managed care systems

T2 - Treating depression in primary care

AU - McFarland, Bentson

PY - 1994/12/19

Y1 - 1994/12/19

N2 - This article addresses the management of depression in primary care from the perspective of a health maintenance organization. The rise of managed care systems is briefly discussed with reference to their impact on choice of treatment strategies. Cost-effectiveness considerations pertinent to a health maintenance organization are reviewed. A simplified protocol for the treatment of depression with paroxetine or imipramine in the primary care sector is presented and used as an example of cost calculations. Given the assumptions used in this cost-effectiveness model, it appears that the costs of treating depression in primary care with paroxetine are approximately equal to those found with the use of imipramine. Higher acquisition costs of paroxetine are balanced by the greater labor costs associated with imipramine.

AB - This article addresses the management of depression in primary care from the perspective of a health maintenance organization. The rise of managed care systems is briefly discussed with reference to their impact on choice of treatment strategies. Cost-effectiveness considerations pertinent to a health maintenance organization are reviewed. A simplified protocol for the treatment of depression with paroxetine or imipramine in the primary care sector is presented and used as an example of cost calculations. Given the assumptions used in this cost-effectiveness model, it appears that the costs of treating depression in primary care with paroxetine are approximately equal to those found with the use of imipramine. Higher acquisition costs of paroxetine are balanced by the greater labor costs associated with imipramine.

UR - http://www.scopus.com/inward/record.url?scp=43949154880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43949154880&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(94)90363-8

DO - 10.1016/0002-9343(94)90363-8

M3 - Article

C2 - 7992827

AN - SCOPUS:43949154880

VL - 97

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 6 SUPPL. 1

ER -